IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

XTL Biopharmaceuticals LTD

CUSIP: 98386D208 | 10 institutional holders

Quarters

Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2016

Sabby Management, LLC724,134
0.0% of portfolio›$434
Invesco Ltd.129,811
0.0% of portfolio›$82
Citadel Advisors LLC83,175
0.0% of portfolio›$50
UBS Group AG16,940
0.0% of portfolio›$11
Morgan Stanley3,400
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Sabby Management, LLC
724,134$4340.0%GrowthVery HighMiami Beach, FL2017-02-14
Invesco Ltd.
129,811$820.0%GrowthLowAtlanta, GA2017-02-14
Citadel Advisors LLC
83,175$500.0%CoreVery HighMiami, FL2017-02-10
UBS Group AG
16,940$110.0%CoreMediumZurich, Switzerland2017-02-14
Morgan Stanley
3,400$20.0%CoreLowNew York, NY2017-02-22